ANX Financial Facts
Loss from operations: -5.59MImpairment loss: 0
See Full Income Statement
Other assets: 43.91K
Property and equipment, net: 198.71K
See Full Balance Sheet
Earnings History for Adventrx Pharmaceuticals, Inc. (ANX)
|
Expand Research on ANX
| Next EPS Date | 3/7/13 *Est. | EPS Growth Rate | +46.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -24.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/12  |
Q312 | -$0.07 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | 0% | Details | |
| 8/6/12 | Q212 | $0.09 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | 0% | Details | |
| 5/7/12 | Q112 | -$0.09 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | 0% | Details | |
| 3/7/12 | Q411 | -$0.06 | -$0.09 | +$0.03 | N/A | N/A | N/A / N/A | N/A | 0% | Details | |
| 11/7/11 |
Q311 | -$0.13 | -$0.13 | $0.00 | N/A | N/A | N/A / N/A | N/A | -29.8% | Details | |
| 5/9/11 |
Q111 | -$0.13 | -$0.26 | +$0.13 | N/A | N/A | N/A / N/A | N/A | -71.6% | Details | |
| 3/10/11 | Q410 | -$0.15 | -$0.18 | +$0.03 | N/A | N/A | N/A / N/A | N/A | -64.6% | Details |
